Back

Intellia Therapeutics Quote, Financials, Valuation and Earnings

Introducing The Great $2 AI Moonshot

Open your free presentation now

Sell

NTLA
Intellia Therapeutics

Last Price:

31.61

Seasonality Move:

10.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street Caliber A.I. for the "Little Guy"

Get the full story here

Intellia Therapeutics Price Quote

$31.61

+0.01 (+-0.47%)

(Updated: September 30, 2023 at 5:52 AM ET)

Intellia Therapeutics Key Stats

Sell

Intellia Therapeutics (NTLA) is a Sell

Day range:

$31.39 - $32.47

52-week range:

$31.13 - $63.12

Dividend yield:

P/E ratio:

0.00

P/S ratio:

49.64

P/B ratio:

2.53%

Volume:

600.5K

Avg. volume:

751.6K

1-year change:

-42.85%

Market cap:

$2.8B

Revenue:

$52.1M

EPS:

$-5.46

How Much Does Intellia Therapeutics Make?

How Much Are Intellia Therapeutics's Sales Annually?
NTLA Revenues are $52.1M
How Much Profit Does Intellia Therapeutics's Make A Year?
NTLA net income is -$474.2M

Is Intellia Therapeutics Growing As A Company?

What Is Intellia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.03%
What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Intellia Therapeutics Stock Price Performance

Did Intellia Therapeutics Stock Go Up Last Month?
Intellia Therapeutics share price went down by -17.26% last month
Did NTLA's Share Price Rise Over The Last Year?
NTLA share price fell by -42.85% over the past 1 year

What Is Intellia Therapeutics 52-Week High & Low?

What Is Intellia Therapeutics’s 52-Week High Share Price?
Intellia Therapeutics has traded as high as $63.12 over the past 52 weeks
What Is Intellia Therapeutics’s 52-Week Low Share Price?
Intellia Therapeutics has traded as low as $31.13 over the past 52 weeks

Intellia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Intellia Therapeutics?

How Much Debt Does Intellia Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Intellia Therapeutics Have?
Cash and short term investments quarterly total is $908.1M
What Is Intellia Therapeutics’s Book Value Per Share?
Book value per share is 12.51

Is Intellia Therapeutics Cash Flow Positive?

What Is NTLA Cash Flow From Operations?
Cash flow from operations (TTM) is -$368M
What Is Intellia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $534.5M
What Is Intellia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$139.3M

Intellia Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
NTLA return on invested capital is -43.29%
What Is Intellia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -35.12%
What Is NTLA Return On Equity?
ROE is a measure of profitability and is -43.29%

Intellia Therapeutics Earnings Date & Stock Price

What Is Intellia Therapeutics's Stock Price Today?
A single share of NTLA can be purchased today for 31.60
What Is Intellia Therapeutics’s Stock Symbol?
Intellia Therapeutics trades on the nasdaq under the ticker symbol: NTLA
When Is Intellia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Intellia Therapeutics is scheduled on November 3, 2023
When Is NTLA's next ex-dividend date?
Intellia Therapeutics's next ex-dividend date is October 1, 2023
How To Buy Intellia Therapeutics Stock?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Intellia Therapeutics Competitors

Who Are Intellia Therapeutics's Competitors?
Below is a list of companies who compete with Intellia Therapeutics or are related in some way:
- Perspective Therapeutics Inc (CATX)
- Electromed Inc (ELMD)
- Navidea Biopharmaceuticals Inc (NAVB)
- Pacific Biosciences of California Inc (PACB)
- Xtant Medical Holdings Inc (XTNT)

Intellia Therapeutics Dividend Yield